Global DPP IV Inhibitor Market Research Report Forecast 2017-2021 Chapter 1 DPP IV Inhibitor Market Overview 1.1 Product Overview and Scope of DPP IV Inhibitor 1.2 DPP IV Inhibitor Market Segmentation by Type 1.2.1 Global Production Market Share of DPP IV Inhibitor by Type in 2015 1.2.1 Type 1 1.2.2 Type 2 1.2.3 Type 3 1.3 DPP IV Inhibitor Market Segmentation by Application 1.3.1 DPP IV Inhibitor Consumption Market Share by Application in 2015 1.3.2 Application 1 1.3.3 Application 2 1.3.4 Application 3 1.4 DPP IV Inhibitor Market Segmentation by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 1.5 Global Market Size (Value) of DPP IV Inhibitor (2012-2021) Chapter 2 Global Economic Impact on DPP IV Inhibitor Industry 2.1 Global Macroeconomic Environment Analysis 2.1.1 Global Macroeconomic Analysis 2.1.2 Global Macroeconomic Environment Development Trend 2.2 Global Macroeconomic Environment Analysis by Regions Chapter 3 Global DPP IV Inhibitor Market Competition by Manufacturers 3.1 Global DPP IV Inhibitor Production and Share by Manufacturers (2015 and 2016) 3.2 Global DPP IV Inhibitor Revenue and Share by Manufacturers (2015 and 2016) 3.3 Global DPP IV Inhibitor Average Price by Manufacturers (2015 and 2016) 3.4 Manufacturers DPP IV Inhibitor Manufacturing Base Distribution, Production Area and Product Type 3.5 DPP IV Inhibitor Market Competitive Situation and Trends 3.5.1 DPP IV Inhibitor Market Concentration Rate 3.5.2 DPP IV Inhibitor Market Share of Top 3 and Top 5 Manufacturers 3.5.3 Mergers & Acquisitions, Expansion Chapter 4 Global DPP IV Inhibitor Production, Revenue (Value) by Region (2012-2017) 4.1 Global DPP IV Inhibitor Production by Region (2012-2017) 4.2 Global DPP IV Inhibitor Production Market Share by Region (2012-2017) 4.3 Global DPP IV Inhibitor Revenue (Value) and Market Share by Region (2012-2017) 4.4 Global DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) 4.5 North America DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) 4.6 Europe DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) 4.7 China DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) 4.8 Japan DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) 4.9 Southeast Asia DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) 4.10 India DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Chapter 5 Global DPP IV Inhibitor Supply (Production), Consumption, Export, Import by Regions (2012-2017) 5.1 Global DPP IV Inhibitor Consumption by Regions (2012-2017) 5.2 North America DPP IV Inhibitor Production, Consumption, Export, Import by Regions (2012-2017) 5.3 Europe DPP IV Inhibitor Production, Consumption, Export, Import by Regions (2012-2017) 5.4 China DPP IV Inhibitor Production, Consumption, Export, Import by Regions (2012-2017) 5.5 Japan DPP IV Inhibitor Production, Consumption, Export, Import by Regions (2012-2017) 5.6 Southeast Asia DPP IV Inhibitor Production, Consumption, Export, Import by Regions (2012-2017) 5.7 India DPP IV Inhibitor Production, Consumption, Export, Import by Regions (2012-2017) Chapter 6 Global DPP IV Inhibitor Production, Revenue (Value), Price Trend by Type 6.1 Global DPP IV Inhibitor Production and Market Share by Type (2012-2017) 6.2 Global DPP IV Inhibitor Revenue and Market Share by Type (2012-2017) 6.3 Global DPP IV Inhibitor Price by Type (2012-2017) 6.4 Global DPP IV Inhibitor Production Growth by Type (2012-2017) Chapter 7 Global DPP IV Inhibitor Market Analysis by Application 7.1 Global DPP IV Inhibitor Consumption and Market Share by Application (2012-2017) 7.2 Global DPP IV Inhibitor Consumption Growth Rate by Application (2012-2017) 7.3 Market Drivers and Opportunities 7.3.1 Potential Applications 7.3.2 Emerging Markets/Countries Chapter 8 Global DPP IV Inhibitor Manufacturers Analysis 8.1 AstraZeneca Plc. (UK) 8.1.1 Company Basic Information, Manufacturing Base and Competitors 8.1.2 Product Type, Application and Specification 8.1.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.1.4 Business Overview 8.2 Boehringer Ingelheim GmbH (Germany) 8.2.1 Company Basic Information, Manufacturing Base and Competitors 8.2.2 Product Type, Application and Specification 8.2.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.2.4 Business Overview 8.3 Eli Lilly and Company (US) 8.3.1 Company Basic Information, Manufacturing Base and Competitors 8.3.2 Product Type, Application and Specification 8.3.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.3.4 Business Overview 8.4 Merck & Co, Inc. (US) 8.4.1 Company Basic Information, Manufacturing Base and Competitors 8.4.2 Product Type, Application and Specification 8.4.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.4.4 Business Overview 8.5 Mitsubishi Tanabe Pharma Corporation (Japan) 8.5.1 Company Basic Information, Manufacturing Base and Competitors 8.5.2 Product Type, Application and Specification 8.5.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.5.4 Business Overview 8.6 Novartis AG (Switzerland) 8.6.1 Company Basic Information, Manufacturing Base and Competitors 8.6.2 Product Type, Application and Specification 8.6.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.6.4 Business Overview 8.7 Takeda Pharmaceutical Company Limited (Japan) 8.7.1 Company Basic Information, Manufacturing Base and Competitors 8.7.2 Product Type, Application and Specification 8.7.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.7.4 Business Overview 8.8 company 8 8.8.1 Company Basic Information, Manufacturing Base and Competitors 8.8.2 Product Type, Application and Specification 8.8.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.8.4 Business Overview 8.9 company 9 8.9.1 Company Basic Information, Manufacturing Base and Competitors 8.9.2 Product Type, Application and Specification 8.9.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.9.4 Business Overview … Chapter 9 DPP IV Inhibitor Manufacturing Cost Analysis 9.1 DPP IV Inhibitor Key Raw Materials Analysis 9.1.1 Key Raw Materials 9.1.2 Price Trend of Key Raw Materials 9.1.3 Key Suppliers of Raw Materials 9.1.4 Market Concentration Rate of Raw Materials 9.2 Proportion of Manufacturing Cost Structure 9.2.1 Raw Materials 9.2.2 Labor Cost 9.2.3 Manufacturing Expenses 9.3 Manufacturing Process Analysis of DPP IV Inhibitor Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers 10.1 DPP IV Inhibitor Industrial Chain Analysis 10.2 Upstream Raw Materials Sourcing 10.3 Raw Materials Sources of DPP IV Inhibitor Major Manufacturers in 2015 10.4 Downstream Buyers Chapter 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Marketing Channel 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List Chapter 12 Market Effect Factors Analysis 12.1 Technology Progress/Risk 12.1.1 Substitutes Threat 12.1.2 Technology Progress in Related Industry 12.2 Consumer Needs/Customer Preference Change 12.3 Economic/Political Environmental Change Chapter 13 Global DPP IV Inhibitor Market Forecast (2017-2021) 13.1 Global DPP IV Inhibitor Production, Revenue Forecast (2017-2021) 13.2 Global DPP IV Inhibitor Production, Consumption Forecast by Regions (2017-2021) 13.3 Global DPP IV Inhibitor Production Forecast by Type (2017-2021) 13.4 Global DPP IV Inhibitor Consumption Forecast by Application (2017-2021) 13.5 DPP IV Inhibitor Price Forecast (2017-2021) Chapter 14 Appendix

Figure Picture of DPP IV Inhibitor Figure Global Production Market Share of DPP IV Inhibitor by Type in 2015 Figure Product Picture of Type I Table Major Manufacturers of Type I Figure Product Picture of Type II Table Major Manufacturers of Type II Figure Product Picture of Type III Table Major Manufacturers of Type III Table DPP IV Inhibitor Consumption Market Share by Application in 2015 Figure Application 1 Examples Figure Application 2 Examples Figure Application 3 Examples Figure North America DPP IV Inhibitor Revenue (Million USD) and Growth Rate (2012-2021) Figure Europe DPP IV Inhibitor Revenue (Million USD) and Growth Rate (2012-2021) Figure China DPP IV Inhibitor Revenue (Million USD) and Growth Rate (2012-2021) Figure Japan DPP IV Inhibitor Revenue (Million USD) and Growth Rate (2012-2021) Figure Southeast Asia DPP IV Inhibitor Revenue (Million USD) and Growth Rate (2012-2021) Figure India DPP IV Inhibitor Revenue (Million USD) and Growth Rate (2012-2021) Figure Global DPP IV Inhibitor Revenue (Million UDS) and Growth Rate (2012-2021) Table Global DPP IV Inhibitor Capacity of Key Manufacturers (2015 and 2016) Table Global DPP IV Inhibitor Capacity Market Share by Manufacturers (2015 and 2016) Figure Global DPP IV Inhibitor Capacity of Key Manufacturers in 2015 Figure Global DPP IV Inhibitor Capacity of Key Manufacturers in 2016 Table Global DPP IV Inhibitor Production of Key Manufacturers (2015 and 2016) Table Global DPP IV Inhibitor Production Share by Manufacturers (2015 and 2016) Figure 2015 DPP IV Inhibitor Production Share by Manufacturers Figure 2016 DPP IV Inhibitor Production Share by Manufacturers Table Global DPP IV Inhibitor Revenue (Million USD) by Manufacturers (2015 and 2016) Table Global DPP IV Inhibitor Revenue Share by Manufacturers (2015 and 2016) Table 2015 Global DPP IV Inhibitor Revenue Share by Manufacturers Table 2016 Global DPP IV Inhibitor Revenue Share by Manufacturers Table Global Market DPP IV Inhibitor Average Price of Key Manufacturers (2015 and 2016) Figure Global Market DPP IV Inhibitor Average Price of Key Manufacturers in 2015 Table Manufacturers DPP IV Inhibitor Manufacturing Base Distribution and Sales Area Table Manufacturers DPP IV Inhibitor Product Type Figure DPP IV Inhibitor Market Share of Top 3 Manufacturers Figure DPP IV Inhibitor Market Share of Top 5 Manufacturers Table Global DPP IV Inhibitor Capacity by Regions (2012-2017) Figure Global DPP IV Inhibitor Capacity Market Share by Regions (2012-2017) Figure Global DPP IV Inhibitor Capacity Market Share by Regions (2012-2017) Figure 2015 Global DPP IV Inhibitor Capacity Market Share by Regions Table Global DPP IV Inhibitor Production by Regions (2012-2017) Figure Global DPP IV Inhibitor Production and Market Share by Regions (2012-2017) Figure Global DPP IV Inhibitor Production Market Share by Regions (2012-2017) Figure 2015 Global DPP IV Inhibitor Production Market Share by Regions Table Global DPP IV Inhibitor Revenue by Regions (2012-2017) Table Global DPP IV Inhibitor Revenue Market Share by Regions (2012-2017) Table 2015 Global DPP IV Inhibitor Revenue Market Share by Regions Table Global DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table North America DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table Europe DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table China DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table Japan DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table Southeast Asia DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table India DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table Global DPP IV Inhibitor Consumption Market by Regions (2012-2017) Table Global DPP IV Inhibitor Consumption Market Share by Regions (2012-2017) Figure Global DPP IV Inhibitor Consumption Market Share by Regions (2012-2017) Figure 2015 Global DPP IV Inhibitor Consumption Market Share by Regions Table North America DPP IV Inhibitor Production, Consumption, Import & Export (2012-2017) Table Europe DPP IV Inhibitor Production, Consumption, Import & Export (2012-2017) Table China DPP IV Inhibitor Production, Consumption, Import & Export (2012-2017) Table Japan DPP IV Inhibitor Production, Consumption, Import & Export (2012-2017) Table Southeast Asia DPP IV Inhibitor Production, Consumption, Import & Export (2012-2017) Table India DPP IV Inhibitor Production, Consumption, Import & Export (2012-2017) Table Global DPP IV Inhibitor Production by Type (2012-2017) Table Global DPP IV Inhibitor Production Share by Type (2012-2017) Figure Production Market Share of DPP IV Inhibitor by Type (2012-2017) Figure 2015 Production Market Share of DPP IV Inhibitor by Type Table Global DPP IV Inhibitor Revenue by Type (2012-2017) Table Global DPP IV Inhibitor Revenue Share by Type (2012-2017) Figure Production Revenue Share of DPP IV Inhibitor by Type (2012-2017) Figure 2015 Revenue Market Share of DPP IV Inhibitor by Type Table Global DPP IV Inhibitor Price by Type (2012-2017) Figure Global DPP IV Inhibitor Production Growth by Type (2012-2017) Table Global DPP IV Inhibitor Consumption by Application (2012-2017) Table Global DPP IV Inhibitor Consumption Market Share by Application (2012-2017) Figure Global DPP IV Inhibitor Consumption Market Share by Application in 2015 Table Global DPP IV Inhibitor Consumption Growth Rate by Application (2012-2017) Figure Global DPP IV Inhibitor Consumption Growth Rate by Application (2012-2017) Table AstraZeneca Plc. (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors Table AstraZeneca Plc. (UK) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table AstraZeneca Plc. (UK) DPP IV Inhibitor Market Share (2012-2017) Table Boehringer Ingelheim GmbH (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors Table Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Market Share (2012-2017) Table Eli Lilly and Company (US) Basic Information, Manufacturing Base, Production Area and Its Competitors Table Eli Lilly and Company (US) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table Eli Lilly and Company (US) DPP IV Inhibitor Market Share (2012-2017) Table Merck & Co, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors Table Merck & Co, Inc. (US) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table Merck & Co, Inc. (US) DPP IV Inhibitor Market Share (2012-2017) Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information, Manufacturing Base, Production Area and Its Competitors Table Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Market Share (2012-2017) Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors Table Novartis AG (Switzerland) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table Novartis AG (Switzerland) DPP IV Inhibitor Market Share (2012-2017) Table Takeda Pharmaceutical Company Limited (Japan) Basic Information, Manufacturing Base, Production Area and Its Competitors Table Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Market Share (2012-2017) Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors Table company 8 DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table company 8 DPP IV Inhibitor Market Share (2012-2017) Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors Table company 9 DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017) Table company 9 DPP IV Inhibitor Market Share (2012-2017) … Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of DPP IV Inhibitor Figure Manufacturing Process Analysis of DPP IV Inhibitor Figure DPP IV Inhibitor Industrial Chain Analysis Table Raw Materials Sources of DPP IV Inhibitor Major Manufacturers in 2015 Table Major Buyers of DPP IV Inhibitor Table Distributors/Traders List Figure Global DPP IV Inhibitor Production and Growth Rate Forecast (2017-2021) Figure Global DPP IV Inhibitor Revenue and Growth Rate Forecast (2017-2021) Table Global DPP IV Inhibitor Production Forecast by Regions (2017-2021) Table Global DPP IV Inhibitor Consumption Forecast by Regions (2017-2021) Table Global DPP IV Inhibitor Production Forecast by Type (2017-2021) Table Global DPP IV Inhibitor Consumption Forecast by Application (2017-2021)

AstraZeneca Plc. (UK) Boehringer Ingelheim GmbH (Germany) Eli Lilly and Company (US) Merck & Co, Inc. (US) Mitsubishi Tanabe Pharma Corporation (Japan) Novartis AG (Switzerland) Takeda Pharmaceutical Company Limited (Japan)